Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview.

Article Details

Citation

Mosley JF 2nd, Smith L, Everton E, Fellner C

Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview.

P T. 2015 Jul;40(7):451-62.

PubMed ID
26185406 [ View in PubMed
]
Abstract

Sodium-glucose linked transporter 2 inhibitors limit the reabsorption of glucose from glomerular filtrate in the kidneys, reducing blood glucose levels in patients with type- 2 diabetes. This article is meant to evaluate this class of medications for clinicians.

DrugBank Data that Cites this Article

Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
CanagliflozinCytochrome P450 3A4ProteinHumans
Unknown
Substrate
Details